Featured News
LuGENE® Lupus Test Launches to Predict Flares & Drug Targets
AMPEL BioSolutions’ Precision Medicine Breakthrough Predicts Drug Options with RNA Analytics & Machine Learning
Virginia Workforce Award to AMPEL BioSolutions
AMPEL on Bloomberg Markets
Lupus, coronary artery disease share genetic risk factors; data may lead to early testing
Innovator-of-Year to AMPEL
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
The question that today’s publication addresses with the multicenter, randomized, double-blind, placebo-controlled ORKIDS trial was whether inflammatory disease activity of people living with Lupus was influenced with a “food as medicine” approach of Omega3 Krill Oil supplementation.
AMPEL BioSolutions: Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
The results indicate that Lupus patients have suboptimal omega-3 (measured in red blood cell membranes using the standard omega3 index) which was normalized by one month supplementation with Krill Oil.
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
AMPEL BioSolutions, with collaborators Lupus Therapeutics and Aker Biomarine, revealed peer-reviewed results that supplementation with Omega3-rich Krill Oil improves disease activity of autoimmune Lupus patients.
Wellness Approach with Lupus & Krill Oil
CLICK FOR ORIGINAL FACEBOOK POST > "Very Interesting. Please Read! Another Lupus Breakthrough!! Wellness Approach to Lupus w/KrillOil Disease activity of #Lupus decreased in a trial of 20sites across the #usa-#canada with Ampel Biosolutions Aker BioMarine ASA-Lupus...
Study Shows Krill Oil Improves Omega-3 Deficiency in Lupus Patients with Early Signs of Lessening Disease Activity in Patients with Severe Lupus
Increasing Omega-3 Index to an optimal level through krill oil supplementation may show benefit for this population and warrants further study.
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
Dr. Peter Lipsky, AMPEL BioSolutions’ Co-Founder, CEO and Chief Medical Officer, “The ORKIDS clinical trial of Krill Oil supplementation for Lupus was a team effort that documented patients were uniformly omega-3 fatty acid deficient which was reversible with Krill Oil supplementation.
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
Research has shown that people with lupus are at an elevated risk of inflammation and cardiovascular complications,” said Dr. Amrie Grammer, AMPEL BioSolutions’ Co-Founder, President and CSO
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
On behalf of LuCIN investigators, I am pleased to report the results of Krill Oil supplementation for Lupus which found that patients are, indeed, deficient in omega3 and this can be safely corrected
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
The ORKIDS clinical trial of Krill Oil supplementation for Lupus was a team effort that documented patients were uniformly omega-3 fatty acid deficient which was reversible with Krill Oil supplementation.
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
The results indicate that Lupus patients have suboptimal omega-3 (measured in red blood cell membranes using the standard omega3 index) which was normalized by one month supplementation with Krill Oil.
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
AMPEL works with Pharma/Biotech customers as a CRO designing & operationalizing clinical trials as well as a biomarker partner for target identification, pre-clinical models, post-hoc analysis and real-time enrichment during clinical trial enrollment.
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
CLICK FOR ORIGINAL ARTICLE > CHARLOTTESVILLE, Va., July 15, 2024 /PRNewswire/ -- Today AMPEL BioSolutions, with collaborators Lupus Therapeutics and Aker Biomarine, revealed peer-reviewed results that supplementation with Omega3-rich Krill Oil improves disease...